top of page
Search

Clinical Research Mixer’s Curated Research Highlights Sep-Oct 2024

Writer's picture: Tea RomeroTea Romero

Caring beyond Prescriptions:

This section is often the hardest for me to write because I really have to dig to find positive news stories. I aim to highlight positive pharma news that supports patients rather than focusing on investor returns, but it is a true challenge. Patients should always be at the center of clinical research. That said, this positive story, while not directly tied to the pharma industry, does impact our healthcare.

Beginning in the fall of 2024, Johns Hopkins will offer free tuition for medical students from families earning under $300,000 a year. 

We’ve Heard Rumblings:


  • Flu Fighters Get a Golden Egg from the U.S. Government. All this egg-citement has vaccine makers flocking together, CSL Seqirus, Sanofi, and GSK have scored a cool $72 million The grant comes from the Department of Health and Human Services' Center for Biomedical Advanced Research and Development Authority (BARDA) all in the name of national preparedness.



  • Looks like BeiGene is ready to swallow the competition in the U.S. cancer drug market with their new option for esophageal squamous cell carcinoma patients. BeiGene launched its cancer drug Tevimbra in the U.S. after the FDA's green light. And guess what? It’s priced 10% lower than its rivals for esophageal cancer. So, what does that mean? Well, it’ll only set you back about $15,075 a month at wholesale—bargain-hunting for your health!



  •  Nothing humorous about our support for hurricane relief efforts. Texas A&M helps out by deploying their Veterinary Emergency Team (VET) to North Carolina in response to Hurricane Helene. Hurricane Helene has been reported as the deadliest hurricane in the North Carolins’s history. The deployment was coordinated by the Texas Division of Emergency Management under the direction of Governor Greg Abbott to support search and rescue operations involving canine teams. The Texas A&M College of Veterinary Medicine and Biomedical Sciences has been a steadfast supporter of the Texas A&M Task Force 1 Urban Search & Rescue (USAR) team since its establishment in 1997.


 

The More You Know:

Imagine being the first dog in the world to be neutered without surgery. Instead of going under the knife, receiving a simple injection at home while being comforted by your loving owner. This could be a new reality for many pets.

The new method uses a vaccine called Egalitte, developed by Dr. Leonardo Saenz from the University of Chile (Fun Fact: I studied as an exchange student at this University in Santiago, Vamos #Chunchito!)  This immunocastration vaccine works by blocking the hormone responsible for reproduction. The best part? It's reversible, giving pet owners more flexibility in their decisions about their pets' reproductive futures.

Costing about $54, the vaccine is available for both male and female dogs but still requires a veterinarian's prescription. Dr. Saenz believes this less invasive method could revolutionize pet population control, making it easier to neuter animals on a wider scale.

Hall of Shame:

Over the past decade, one of America's largest contract drug manufacturing facilities has been playing a risky game of "Oops, I Did It Again" with FDA regulations. The plant, owned by science giant Thermo Fisher Scientific, has repeatedly failed to follow rules designed to keep our meds contamination-free. Noting, that as of October 2024, no harm to humans has been documented from this contamination breach.

1 view0 comments

Recent Posts

See All

Comments


Subscribe Form

Thanks for submitting!

  • LinkedIn
  • Instagram

©2021 by Leaders In Clinical Research. Proudly created with Wix.com

bottom of page